Namrata Chand
Investor Relations Kontakt bei Ryca International, Inc.
Aktive Positionen von Namrata Chand
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Ryca International, Inc. | Investor Relations Kontakt | - | - |
Karriereverlauf von Namrata Chand
Ehemalige bekannte Positionen von Namrata Chand
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| QSAM BIOSCIENCES, INC. | Geschäftsführer | - | - |
| Public Communications Contact | - | - | |
| Corporate Officer/Principal | 01.11.2020 | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Operating Officer | 1 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
| Ryca International, Inc. |
- Börse
- Insiders
- Namrata Chand
- Erfahrung
